Psyence Biomedical (PBM) Prepaid Assets (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly Prepaid Assets of $251796.0 in Q1 2025, down 21.83% quarter-over-quarter from $322126.0 in Q1 2024, and down 21.83% on a YoY basis from $322126.0 in Q1 2024.
Psyence Biomedical (PBM) Prepaid Assets (2023 - 2025) Analysis & Trends
Psyence Biomedical's Prepaid Assets history runs 3 years deep, the most recent figure standing at $251796.0 for Q1 2025.
- In Q1 2025, Prepaid Assets fell 21.83% year-over-year to $251796.0; the TTM figure through Mar 2025 stood at $251796.0 (down 21.83% YoY), while the FY2025 annual figure was $251796.0, down 21.83% from the prior year.
- Prepaid Assets was $251796.0 for Q1 2025 at Psyence Biomedical, down from $322126.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $322126.0 in Q1 2024 to a low of $77050.0 in Q1 2023.
- Historically, Prepaid Assets has averaged $216990.7 across 3 years, with a median of $251796.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 318.07% in 2024, then fell 21.83% in 2025.
- A 3-year view of Prepaid Assets shows it stood at $77050.0 in 2023, then surged by 318.07% to $322126.0 in 2024, then dropped by 21.83% to $251796.0 in 2025.
- The last three Prepaid Assets figures came in at $251796.0 (Q1 2025), $322126.0 (Q1 2024), and $77050.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 251,796.00 |
| Mar 31, 2024 | 322,126.00 |
| Mar 31, 2023 | 77,050.00 |